ArticleOncology letters2014

Inhibition of phosphoinositide 3-kinase/Akt pathway decreases hypoxia inducible factor-1α expression and increases therapeutic efficacy of paclitaxel in human hypoxic gastric cancer cells.

Jing Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.